LONG-TERM EFFECT OF ACARBOSE ON DIURNAL SERUM TRIGLYCERIDE, GLUCOSE, INSULIN AND ADIPOSE-TISSUE LIPOPROTEIN-LIPASE LEVELS IN PATIENTS WITH PRIMARY ENDOGENOUS HYPERTRIGLYCERIDEMIA, WITH OR WITHOUT TYPE-II DIABETES

This publication has 12 references indexed in Scilit:

• Improvement of metabolic control in insulin dependent diabetics treated with the ?-glucosidase inhibitor Acarbose for two months
  Diabetologia, 1981
• Diurnal Levels of Lipids, Glucose and Insulin in Type IV Hyperlipidemic Patients on High Carbohydrate and High Fat Diet: Comparison with Normals
  Acta Medica Scandinavica, 1981
• Effect of the?? glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics
  Diabetologia, 1979
• The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1979
• The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1979
• Inhibition of human intestinalα-glucosidehydrolases by a new complex oligosaccharide
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1979
• The influence of meal frequency on diurnal lipid, glucose and cortisol levels in normal subjects
  European Journal of Clinical Investigation, 1978
• Role of Insulin in Endogenous Hypertriglyceridemia*
  Journal of Clinical Investigation, 1967
• QUANTITATIVE ASPECTS OF THE REACTION BETWEEN INSULIN AND INSULIN-BINDING ANTIBODY
  Journal of Clinical Investigation, 1959
• A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITY
  Journal of Biological Chemistry, 1952